Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference
November 10 2021 - 4:05PM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”)
today announced that the company will deliver a corporate
presentation during the 2021 Jefferies London Healthcare Conference
-- November 16-19, 2021. The presentation will be available to all
conference attendees on demand (link here) beginning on
Thursday, November 18 at 8 am GMT/3 am EST through Friday,
November 19 at 5 pm GMT/12 pm EST.
Interested parties can also register and access the on-demand
webcast through the Investor section of the Aurinia corporate
website - www.auriniapharma.com, under "News/Events.”
ABOUT AURINIA
Aurinia is a fully integrated biopharmaceutical company focused
on delivering therapies to treat targeted patient populations that
are impacted by serious diseases with a high unmet medical need.
The Company recently introduced the first FDA-approved oral therapy
indicated for the treatment of adult patients with active lupus
nephritis (LN). Aurinia’s head office is in Victoria, British
Columbia; its U.S. commercial hub is in Rockville, Maryland; and
the Company focuses development efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211110005974/en/
Investor and Corporate: Dana Lynch, IR & Corporate
Communications dlynch@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2023 to Apr 2024